
Sign up to save your podcasts
Or
Chad Robins, CEO and Co-founder of Adaptive Biotechnologies, discusses their recent partnership with Microsoft to decode the immune system's response to CODVID-19 and develop better diagnostic tools and their partnership with Amgen to develop potential antibody therapies to treat the disease. Chad also shares how the medical field is adapting and facing new challenges during this pandemic.
See omnystudio.com/listener for privacy information.
4.9
7777 ratings
Chad Robins, CEO and Co-founder of Adaptive Biotechnologies, discusses their recent partnership with Microsoft to decode the immune system's response to CODVID-19 and develop better diagnostic tools and their partnership with Amgen to develop potential antibody therapies to treat the disease. Chad also shares how the medical field is adapting and facing new challenges during this pandemic.
See omnystudio.com/listener for privacy information.
522 Listeners
2,633 Listeners
5,434 Listeners
1,164 Listeners